HealthSpan Partners to Acquire Surgery Partners for $5.7B
The all-cash buyout will take the surgical facility operator private and result in a delisting from the Nasdaq.
Updated on Oct. 26, 2026 in Healthcare
Live Poll
Does seeing a major company acquisition make you more likely to increase your stock market investments?
HealthSpan Partners has launched a bid to acquire surgical operator Surgery Partners for $5.7 billion. The all-cash offer will result in Surgery Partners being delisted from the Nasdaq once the transaction closes.
Why it matters
The deal signals a significant consolidation in the outpatient surgery market as HealthSpan seeks to integrate a portfolio of over 200 facilities operating across 30 states. Investors and operators should watch for how such large-scale acquisitions impact competitive pricing for medical services.
The $5.7 billion offer provides $23.50 per share in cash, a 49% premium over the October 23, 2026, closing price. Surgery Partners shares rose more than 46% following the announcement, reflecting a shift for the operator of 200 facilities across 30 states.
The players
HealthSpan Partners
An investment firm and potential acquirer currently expanding its portfolio in the medical sector.
Surgery Partners
A national operator of more than 200 surgical facilities across 30 states currently listed on the Nasdaq.
Bain Capital
An investment firm that owns approximately 39% of Surgery Partners.
The details
Under the terms of the deal, shareholders excluding Bain Capital affiliates will receive $23.50 per share in cash. Bain Capital, which currently holds a 39% stake in Surgery Partners, will exchange its existing equity for ownership in HealthSpan Partners. Once the acquisition is finalized, Surgery Partners will cease its independent public trading and be delisted from the Nasdaq exchange.
Timeline
October 23, 2026: The base date for the 49% premium calculation.
October 26, 2026: Surgery Partners shares surge more than 46% during morning trade.
Q1 2027: The expected closing date for the acquisition.
Market Landscape
The stock's single-day jump marks the largest gain for the entity since the 2020 market volatility period. This acquisition reflects a broader trend of private equity interest in scaling multisite healthcare platforms through privatization.
Operators in the outpatient surgery space should monitor this transition as a signal of ongoing consolidation and valuation shifts. Managers should prepare for potential integration-related changes in vendor contracts and procurement protocols once the deal closes.
The takeaway
This deal underscores the aggressive consolidation strategies currently targeting large-scale surgical service providers. Operators should audit current service agreements and watch for further industry shifts as private equity capital continues to reshape ownership of clinical infrastructure.
What happens next
The acquisition is scheduled to close in the first quarter of 2027, at which point Surgery Partners will be delisted from the Nasdaq.
Further reading
For broader trends on private equity involvement in the medical field, visit Healthcare.
Live Poll
Does seeing a major company acquisition make you more likely to increase your stock market investments?
